Komori
Share Issuance and Disposal6568KNC Laboratories Co.,Ltd.Information and Communications, Services and Others

Notice of Completion of Payment for the Disposal of Treasury Shares as Restricted Stock-Based Compensation

Payment by the recipients for the disposal of 8,200 treasury shares as restricted stock compensation has been completed.

Worth reading
24Immaterial
Scored from 4 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
10405800
¥
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Disposal of treasury shares as restricted stock compensation

Who receives how much8,200Shares

8,200 common shares of the Company (treasury shares)

4 directors (excluding outside directors)7,800 shares
2 executive officers400 shares

The height of each bar represents the proportion of shares received by each allottee. The thin line below represents the number of existing shares to which these shares are added.

¥1,269 per share
Categories and Number of Persons Covered
Category Directors (excluding outside directors) / Number of Employees 4 / Number of allocated shares 7,800 shares, Category Executive officers / Number of Employees 2 / Number of allocated shares 400 shares
Payment date
7 August 2026
Details of issuance or disposal
ItemDetails
Type of issuance or disposalDisposal of treasury shares as restricted stock compensation
Number of shares to be issued or disposed of8,200 common shares of the Company (treasury shares)
Issue price and disposal price¥1,269 per share
Payment date7 August 2026
Intended allotteeCategory 4 directors (excluding outside directors) / Number of Shares 7,800 shares, Category 2 executive officers / Number of Shares 400 shares
Categories and Number of Persons CoveredCategory Directors (excluding outside directors) / Number of Employees 4 / Number of allocated shares 7,800 shares, Category Executive officers / Number of Employees 2 / Number of allocated shares 400 shares
Items this document does not state (22)
Total issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise priceExercise periodNumber of Stock Acquisition RightsTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The payment procedures for the disposal of treasury shares as restricted stock compensation approved at the Board of Directors meeting held on 21 July 2026 have been completed.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Completion of Payment for the Disposal of Treasury Shares as Restricted Stock-Based Compensation | KNC Laboratories Co.,Ltd. (6568) timely disclosure | Komori